{"entity":{"type":"insider","cik":"0001432303","url":"/insider/0001432303","json_url":"/insider/0001432303.json","name":"Morris Richard Steven","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":7,"first":"2008-09-15","last":"2021-05-21","span_basis":"filed_date"},"name_variants":[{"name":"Morris Richard Steven","source":"filing","n_filings":7,"first_seen":"2008-09-15","last_seen":"2021-05-21"}],"transactions":[{"id":4093446,"accession":"0001209191-21-035059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-035059","line_url":"/filing/0001209191-21-035059#line-1","is_derivative":false,"issuer_cik":"0001432303","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001432303","owner_cik":"0001432303","owner_name":"Morris Richard Steven","owner_display_name":"Morris Richard Steven","owner_url":"/insider/0001432303","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2171.0,"shares_display":"2,171","price_per_share":13.8183,"price_display":"13.82","price_state":"stated","total_value":29999.5293,"total_display":"29,999.53","total_whole":"30,000","shares_owned_after":5454.0,"shares_owned_after_display":"5,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-21","filed_date":"2021-05-21","scope":"insider"},{"id":2109139,"accession":"0001209191-20-015629","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-015629","line_url":"/filing/0001209191-20-015629#line-1","is_derivative":false,"issuer_cik":"0001432303","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001432303","owner_cik":"0001432303","owner_name":"Morris Richard Steven","owner_display_name":"Morris Richard Steven","owner_url":"/insider/0001432303","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":7200.0,"total_display":"7,200.00","total_whole":"7,200","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-03","scope":"insider"},{"id":2627064,"accession":"0001127602-12-010405","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-010405","line_url":"/filing/0001127602-12-010405#line-2","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001432303","owner_name":"Morris Richard Steven","owner_display_name":"Morris Richard Steven","owner_url":"/insider/0001432303","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":29.7062,"price_display":"29.71","price_state":"stated","total_value":38618.06,"total_display":"38,618.06","total_whole":"38,618","shares_owned_after":1244.0,"shares_owned_after_display":"1,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-09","filed_date":"2012-03-12","scope":"insider"},{"id":2733274,"accession":"0001127602-12-009884","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-12-009884","line_url":"/filing/0001127602-12-009884#line-3","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001432303","owner_name":"Morris Richard Steven","owner_display_name":"Morris Richard Steven","owner_url":"/insider/0001432303","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":33.01,"price_display":"33.01","price_state":"stated","total_value":174953.0,"total_display":"174,953.00","total_whole":"174,953","shares_owned_after":1244.0,"shares_owned_after_display":"1,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-05","filed_date":"2012-03-07","scope":"insider"},{"id":9109388,"accession":"0001127602-11-029930","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-11-029930","line_url":"/filing/0001127602-11-029930#line-2","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001432303","owner_name":"Morris Richard Steven","owner_display_name":"Morris Richard Steven","owner_url":"/insider/0001432303","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":22.5903,"price_display":"22.59","price_state":"stated","total_value":45180.6,"total_display":"45,180.60","total_whole":"45,181","shares_owned_after":1165.0,"shares_owned_after_display":"1,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-16","filed_date":"2011-11-17","scope":"insider"},{"id":7455278,"accession":"0001127602-10-030242","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001127602-10-030242","line_url":"/filing/0001127602-10-030242","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001432303","owner_name":"Morris Richard Steven","owner_display_name":"Morris Richard Steven","owner_url":"/insider/0001432303","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13300.0,"shares_display":"13,300","price_per_share":16.56,"price_display":"16.56","price_state":"stated","total_value":220248.0,"total_display":"220,248.00","total_whole":"220,248","shares_owned_after":3869.0,"shares_owned_after_display":"3,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-09","filed_date":"2010-12-10","scope":"insider","n_lines":2},{"id":7455270,"accession":"0001127602-10-030242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-10-030242","line_url":"/filing/0001127602-10-030242#line-2","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001432303","owner_name":"Morris Richard Steven","owner_display_name":"Morris Richard Steven","owner_url":"/insider/0001432303","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":16.55,"price_display":"16.55","price_state":"stated","total_value":19860.0,"total_display":"19,860.00","total_whole":"19,860","shares_owned_after":569.0,"shares_owned_after_display":"569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-08","filed_date":"2010-12-10","scope":"insider"},{"id":3042492,"accession":"0001181431-08-053075","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-08-053075","line_url":"/filing/0001181431-08-053075","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001432303","owner_name":"Morris Richard Steven","owner_display_name":"Morris Richard Steven","owner_url":"/insider/0001432303","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":14.297168181818181,"price_display":"14.30","price_state":"stated","total_value":31453.77,"total_display":"31,453.77","total_whole":"31,454","shares_owned_after":1054.0,"shares_owned_after_display":"1,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-11","filed_date":"2008-09-15","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001787297","name":"Passage BIO, Inc.","url":"/issuer/0001787297","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2020-03-03","last_seen":"2021-05-21"},{"type":"issuer","type_label":"ISSUER","cik":"0000946840","name":"VIROPHARMA INC","url":"/issuer/0000946840","role":"Officer (Chief Accounting Officer)","n_filings":5,"first_seen":"2008-09-15","last_seen":"2012-03-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001432303","retrieved_at":"2026-08-24T13:15:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}